<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D3B1451F-3B0D-4EE1-91A4-52B87BB1DBA0"><gtr:id>D3B1451F-3B0D-4EE1-91A4-52B87BB1DBA0</gtr:id><gtr:name>Don Whitley Scientific Limited</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF9ACCD7-5AF4-49DE-9F89-3FB101F65D11"><gtr:id>BF9ACCD7-5AF4-49DE-9F89-3FB101F65D11</gtr:id><gtr:name>Intercytex</gtr:name><gtr:address><gtr:line1>Innovation House</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:postCode>M23 9QR</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43F4F425-AC3C-4250-B7B8-9187B7329DC8"><gtr:id>43F4F425-AC3C-4250-B7B8-9187B7329DC8</gtr:id><gtr:name>Tokyo Electron and FBRI Kobe</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Medical and Human Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D3B1451F-3B0D-4EE1-91A4-52B87BB1DBA0"><gtr:id>D3B1451F-3B0D-4EE1-91A4-52B87BB1DBA0</gtr:id><gtr:name>Don Whitley Scientific Limited</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF9ACCD7-5AF4-49DE-9F89-3FB101F65D11"><gtr:id>BF9ACCD7-5AF4-49DE-9F89-3FB101F65D11</gtr:id><gtr:name>Intercytex</gtr:name><gtr:address><gtr:line1>Innovation House</gtr:line1><gtr:line2>Crewe Road</gtr:line2><gtr:postCode>M23 9QR</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0164CD1-D64C-4811-88B8-67B800E02651"><gtr:id>A0164CD1-D64C-4811-88B8-67B800E02651</gtr:id><gtr:name>Tokyo Electron</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43F4F425-AC3C-4250-B7B8-9187B7329DC8"><gtr:id>43F4F425-AC3C-4250-B7B8-9187B7329DC8</gtr:id><gtr:name>Tokyo Electron and FBRI Kobe</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/72265151-89A7-450E-A15F-F2080AD38054"><gtr:id>72265151-89A7-450E-A15F-F2080AD38054</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Kimber</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F785B423-CFB6-4A4C-B8BA-802DC65552DB"><gtr:id>F785B423-CFB6-4A4C-B8BA-802DC65552DB</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Brison</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801057"><gtr:id>164D2188-7FCE-403F-8998-7ECEE349B90B</gtr:id><gtr:title>Derivation of clinical grade embryonic stem cell lines in Manchester</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801057</gtr:grantReference><gtr:abstractText>During in vitro fertilisation (IVF) treatment many eggs and embryos fail to develop normally and are unsuitable for clinical use and routinely discarded at an early stage. Other embryos are frozen for future use. The purpose of this research is to use these eggs and embryos, with appropriate patient consent, to make human embryonic stem cells. Embryo stem cells are special cells that appear to be able to develop into all cells found in the body. As such they can be used to study early embryo development, how specialized cells form or deteriorate, to test drugs for toxicity, or for therapeutic use in the treatment of degenerative disease or tissue damage. Although many human embryonic stem cell ?lines? exist throughout the world, these are all research grade and are unlikely to be suitable for treatment of diseases. The aim of the proposed research is therefore to make new embryonic stem cells under highly regulated and clinically clean conditions, suitable for transplantation. We have new IVF and stem cell laboratories built and run to these standards and the current proposal requests funding to maintain and run these facilities in order to maximise the production of clinical grade embryonic stem cells. These new cell lines will be deposited in the UK Stem Cell Bank and any clinical treatments and commercial exploitation organised by Central Manchester NHS Trust and the University of Manchester together with the Medical Research Council.</gtr:abstractText><gtr:technicalSummary>The purpose of this proposal is to derive and fully characterise 6-8 new clinical grade human embryonic stem cell (hESC) lines. It will extend the operation of the currently funded NW Embryonic Stem Cell Centre (NWESCC) in Manchester until 2011 in order to fulfil this aim. Recently established GMP cleanroom laboratory facilities funded by the MRC (IVF laboratories at St Mary?s Hospital) and the NW Development Agency (hESC laboratories at the University of Manchester) will be used. Our existing expertise in patient consenting, embryology, derivation and characterisation of hESC lines, Quality Management, and regulatory issues will be exploited and built upon. This will be extended via links and collaborations with other centres eligible for this work, including Edinburgh/Roslin Cells, Nottingham, King?s London, and Birmingham. Embryos from three sources will be used for derivation, including (i) surplus embryos from fresh IVF cycles, (ii) immature or failed-to-fertilise oocytes activated with chemical/parthenogenetic stimuli, and (iii) high quality embryos cryopreserved at the pronucleate stage. Over the last 12-18 months a large number of oocytes and embryos have been donated from the IVF programmes at St Mary?s and Manchester Fertility Services, leading to the derivation of 3 well established research grade hESC lines, RCM-1 (in collaboration with Roslin Cells, Edinburgh), Man-1 and Man-2, the first two of which have been submitted to the UK Stem Cell Bank. Clinical grade lines will be derived employing our established standard operating procedures which will be developed and refined. These make use of significant advances by NWESCC in the areas of xeno-free derivation and culture, feeder-free culture media and a GMP human fibroblast feeder cell line. Regulatory compliance will be maintained via our established Quality Management system and in conjunction with intellectual property departments at the University of Manchester and CMMC NHS Trust who will assist with commercial exploitation of GMP hESC lines in conjunction with MRC.</gtr:technicalSummary><gtr:fund><gtr:end>2013-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1251280</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>UK Platform Project for Automated ESC/iPSC Culture and Differentiation</gtr:description><gtr:id>C7149BFD-48F5-4F53-9638-A93D38DBFAB2</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>NrYjZZaNQQz-1</gtr:outcomeId><gtr:partnerContribution>provision of novel dquipment and system for pluripotent stem cell culture</gtr:partnerContribution><gtr:piContribution>expertise in GMP, ESC and iPSC culture and metabolomic profiling</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Tokyo Electron Ltd, Tokyo Electron Europe</gtr:description><gtr:id>8678C5D2-2972-488D-8AD0-0B87A5E4360D</gtr:id><gtr:impact>not yet</gtr:impact><gtr:outcomeId>54638b6316a0c1.69707088-1</gtr:outcomeId><gtr:partnerContribution>Providing industrial expertise and equipment</gtr:partnerContribution><gtr:piContribution>Developing methods for automated scaleup of stem cell manufacturing</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intercytex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with local SME to develop a new clinically compatible system for hESc derivations</gtr:description><gtr:id>EFA6AAA0-9804-4954-91D4-2A66804F0524</gtr:id><gtr:impact>Project ongoing; Output - TSB grant to facilitate this work. See Section 3.</gtr:impact><gtr:outcomeId>X31Na1fkZkv-1</gtr:outcomeId><gtr:partnerContribution>Provision of material (human dermal fibroblasts) to support the growth and derivation of human Embryonic Stem Cells.</gtr:partnerContribution><gtr:piContribution>ICX supplies the hDFs whilst our research group at NWESCC conducts lab based work to determine whether hDFs support human Embryonic Stem Cell growth.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Intercytex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Intercytex for development of GMP grade human dermal fibroblasts as feeders for derivation of clinically useable human ES cells</gtr:description><gtr:id>66E1DD58-C6AA-4DE5-9B29-5B0A28DA213C</gtr:id><gtr:impact>Grant income of &amp;pound;40,000; collaboration with Intercytex to jointly run GMP laboratories; and successful application to MHRA for product manufacturing licence. This collaboration covers the following disiplines: embryology, stem cell biology, quality management, wound healing.</gtr:impact><gtr:outcomeId>f84MVeV9p9o-1</gtr:outcomeId><gtr:partnerContribution>Development of GMP grade human dermal fibroblasts as feeders for derivation of clinically useable human ES cells</gtr:partnerContribution><gtr:piContribution>Development of GMP grade human dermal fibroblasts as feeders for derivation of clinically useable human ES cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Don Whitley Scientific Limited</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Don Whitley Scientific</gtr:description><gtr:id>8384C858-F440-4BDA-9881-C973DCD878C2</gtr:id><gtr:impact>innovate grant...will put in for CIC and pos P2D</gtr:impact><gtr:outcomeId>56d6b8adeef826.68620787-1</gtr:outcomeId><gtr:partnerContribution>DWS have a work staion whihc h they will upgrade a redesign for controlled atmosphere working. Applied to Innovate for fudning but narrowly missed</gtr:partnerContribution><gtr:piContribution>To develop and evaluate better ways of genrating good manufacturing (clinical) standrd high quality induced pluripotent stem cells at low cost using an environmental work station</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sheffield</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biomedical Science</gtr:department><gtr:description>Collaboration with ISCI2</gtr:description><gtr:id>CFC9A899-A1E1-442E-A440-BE1162EE5DB9</gtr:id><gtr:impact>Paper in press in Nature Biotechnology describing genetic characterisation of 127 embryonic stem cell lines. Disciplines covered are stem cell biology, embryology and genetics.</gtr:impact><gtr:outcomeId>dfPmSi4JANJ-1</gtr:outcomeId><gtr:partnerContribution>Derived and characterised novel stem cell lines in Manchester and submitted these to international initiative for genetic characterisation.</gtr:partnerContribution><gtr:piContribution>Dervied and characterised novel stem cell lines in Manchester and submitted these to international initiative for genetic characterisation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Tokyo Electron and FBRI Kobe</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>TEL</gtr:description><gtr:id>02FAA6E5-AD8C-4F79-BF0D-131866DAF2C2</gtr:id><gtr:impact>Grant applicaion awarded 2015 MRC Mica</gtr:impact><gtr:outcomeId>mw7FEakB6hV-1</gtr:outcomeId><gtr:partnerContribution>Sharing and development of new culture and passaging method for iPSC</gtr:partnerContribution><gtr:piContribution>Development of new iPSC culture an passaging method; Part of MICA consortium grant</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Kings College, University of London</gtr:description><gtr:id>BA0302E8-E2FF-435F-8287-6D260FCF2058</gtr:id><gtr:impact>Collaboration has resulted in clinical grade stem cell lines ready for submission to UKSCB and a Science Media Centre event has been organised to publicise submission of clinical grade stem cell lines to UK Stem Cell Bank. Disciplines covered are embryology, stem cell biology, healthcare science, and quality management.</gtr:impact><gtr:outcomeId>LsQFi1skAg4-1</gtr:outcomeId><gtr:partnerContribution>Sharing bext practice with King's via regular meetings.</gtr:partnerContribution><gtr:piContribution>Sharing bext practice with King's via regular meetings.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Guardian newspaper article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0EFBCAC-F2CD-415A-9D7C-1430E7E432C3</gtr:id><gtr:impact>Guardian newspaper article on ART child health</gtr:impact><gtr:outcomeId>56ddecf3cf1a48.66372587</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bollington Sci Bar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E6D816CF-F556-493B-B90C-11ED2C2C2FD4</gtr:id><gtr:impact>About 60 people attended ...v good feedback

People better informed links with local industry</gtr:impact><gtr:outcomeId>CX7jJ9smVd4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Health point</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>418F83DE-7A16-4604-8CAE-48298A5C82E6</gtr:id><gtr:impact>BBC Radio 4 broadcast a Health point programme featuring OA and including an interview about our work

Work aired in National media</gtr:impact><gtr:outcomeId>DWzr3t8mPcP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lancashire Humanists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9CE23272-50CB-4443-8D1D-4EE752B27CA2</gtr:id><gtr:impact>70 people attenced a public lecture on stem cell biology

Requests for other talks to Humanist groups.</gtr:impact><gtr:outcomeId>YMajzoRVuaG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pluripotent Stem Cells at Cafe Scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2B293797-CD7C-49F2-B35D-F1B026AF0932</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>jeCYYVGMYec</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on News NW</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>B1CEBA60-B024-48B2-A186-883233AEEA56</gtr:id><gtr:impact>Interview broadcast on News NW.

Informed public of opinion on patients seeking treatment abroad.</gtr:impact><gtr:outcomeId>ADUWnLJUpBe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>So what is all this about Stem Cells, Bramhall</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>87C4AF4B-396C-48EC-9643-3376EC9EF559</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>LwuA2edoUAr</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture to EU Student Parliament debate on embryo research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B49EF6B8-0BC4-40BB-A144-1F3BA8B0F770</gtr:id><gtr:impact>Invited lecture to EU Student parliament debate on human embryo research including embryonic stem cell derivation, in Salford, UK</gtr:impact><gtr:outcomeId>58c2cc3d81d642.34282301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cell Therapy Catapult</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>02F68C4D-88F7-4ADA-858D-D7D4A661FAC7</gtr:id><gtr:impact>We were informing the Catapult of our activities towerds Cell therapy for Cartilage. They were advising us on most optimal way forward.

Beter informed on both sides</gtr:impact><gtr:outcomeId>565deb015ec506.74437247</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UKSCN Stem Cell Roadshow: Stem Cell Treatments Where Are We?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D247EB12-0AF5-4745-B465-329A29B3D67E</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>bYkvtA9TEeh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxbridge Roundtable Manchester 2012</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>52C9BFB7-2AAE-426D-9FBC-03CCC6001CA1</gtr:id><gtr:impact>50 undergraduate students attended.

Stem cell application discussed.</gtr:impact><gtr:outcomeId>aY96JEsryDm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre press conference</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>17D28F6B-29B6-4724-AD86-7AEA66168736</gtr:id><gtr:impact>Press conference organised by SMC to discuss press release concerning submission of clinical grade embryonic stem cell lines to the UK Stem Cell Bank

Interest from media, followup stories. Followup contacts from industry resulting directly from press release.</gtr:impact><gtr:outcomeId>RS1hsH2BEqL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Women in Science Becoming the Best</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>837EB2DB-9EDF-4454-AB04-803CE924EB2E</gtr:id><gtr:impact>Dissemaination of information advice and support for women's role and leadership in scince</gtr:impact><gtr:outcomeId>56d6cc414089f7.70058681</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Information for Quality Programme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5FAE2426-78AC-4513-9C96-802E612A81F6</gtr:id><gtr:impact>Membership of HFEA's Information for Quality Programme</gtr:impact><gtr:outcomeId>56ddebc7db4261.70184186</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stockport Academy 6th form Christmas Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>433489DE-40AA-41CE-857B-6BB7CE4BA316</gtr:id><gtr:impact>100 students attended.

Basic stem cell knowledge was dispensed and general questions discussed.</gtr:impact><gtr:outcomeId>Q8X4UK6vVbN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Can Stem Cells Mend our Broken Hearts? Manchester Town Hall</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>98109F02-1B49-4E67-9D17-07D8E6310DB4</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>Vbvs2ekzVUY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>What is the Future for Stem Cells at Cafe Scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E97636BA-BF73-46E0-A2CA-28116F84C820</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>kK47jLVDwMw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Big Bang National and Regional Science Fairs 2010</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>6A010E87-8B00-4A49-9E39-72BBA5C6FE91</gtr:id><gtr:impact>The Big Bang 2010 was held in Manchester over three days in March, attracting 22,500 people, including over 15,000 children and young people and 4,000 of their teachers, parents and guardians. Students were enthused about our research activity and indicated that they were more informed about stem cell research and interested in future placements at the University. Our interactive activities garnered significant interest and raised many interesting questions from students, parents and teachers. Consequently, the Centre was invited to participate in various science fairs/events nationwide.

Various requests for school visits were made by teachers and students and facilitated by the Centre.</gtr:impact><gtr:outcomeId>ZwfxSBaFMoZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7AB5E7BE-2F85-44A7-B3A3-4D58F8A4F7EA</gtr:id><gtr:impact>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:impact><gtr:outcomeId>56ddec29aee746.47408668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Knutsford  sci Bar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>CF514E47-CD70-4D06-8E75-118BC40F61EA</gtr:id><gtr:impact>Around 50 people various backgrounds

audience better informed change of atitude</gtr:impact><gtr:outcomeId>cXcciR7ZaYN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Progress Educational Trust Conference, London: The Robust and Responsive Embryo</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>894FA164-AD4C-498A-AE8D-5854DA18B414</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>ZVcJVPAozqH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview with Mark Porter</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6EF63651-9952-4996-AD0B-5F6EBDB9259F</gtr:id><gtr:impact>Sue Kimber interviewed on Radio 4 Case Notes programme re stem cell therapies

Raised public awareness, led to doubled patient and GP interest in NWESCC</gtr:impact><gtr:outcomeId>BTUKp2y9J24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview re 'Promising' stem cell trials for blindness</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD982A3B-2AE8-4358-B192-83BCE31929F7</gtr:id><gtr:impact>Daniel Brison interviewed and commented on news story re stem cell therapies

Raising public awareness</gtr:impact><gtr:outcomeId>D64dC6mLWBJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CIS talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DD9AD3EA-ECA7-40B4-845E-339CA2808AD5</gtr:id><gtr:impact>Academics form non biological disciplines ( about 25)

Information and dissemination of ideas about research and ethics</gtr:impact><gtr:outcomeId>oE2mgTZwMcH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local SME XCellR8's &quot;Fast Train&quot; training workshop and exhibition on stem cell research.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3E3CADC4-4D10-40E5-9D0F-CB722BA08C84</gtr:id><gtr:impact>Approximately 100 attendees participated in this event; activties arranged throughout the day fuelled interesting discussions and questions.

Increased awareness in stem cell research and interest in the Centre's activities from Healthcare Professionals as well as Industry representatives interested in forging future collaborations.</gtr:impact><gtr:outcomeId>eTYnAGNnLit</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>cafe Scientifique</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B7FC82F4-CF74-469E-BCEB-118305A0EE5F</gtr:id><gtr:impact>About 60 people attended; positive feedback much discussion

People were better informed; pro research a number of patients contacted</gtr:impact><gtr:outcomeId>GkSVTDt2BKQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Regener8: Stem Cell Biology in Translation in the NW and Midlands</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>78156990-E031-4135-AE79-D05665AD1AD2</gtr:id><gtr:impact>Feedback from audiences, questions and discussion, and evaluation forms.

Increased interest in undergraduate placements with the University of Manchester, increased interest from commercial companies in product trials and collaborations with NWESCC, and increased applications from prospective PhD/MD students.</gtr:impact><gtr:outcomeId>U2QRFo8y2q6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MS society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>5CD2E064-4F7F-4C84-AC7C-F476A8D068D8</gtr:id><gtr:impact>100 undergraduate students attended

Question about the stem cell application discussed.</gtr:impact><gtr:outcomeId>GaX9RqsaAz1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Scientist Article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DA01F570-5DBF-46D5-82B6-1D9735E8D66F</gtr:id><gtr:impact>Interview for article in New Scientist on research into ART child health</gtr:impact><gtr:outcomeId>56ddeb57a83b74.45824920</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CMFT Xmas lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>975873CB-98E5-4699-9831-C5AEEC98B3B1</gtr:id><gtr:impact>Xmas Royal Society-style lecture for Central Manchester NHS Foundation Trust &amp;quot;The Stem Cell Revolution&amp;quot;.

School visit requests</gtr:impact><gtr:outcomeId>54638c99079904.93253963</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TERMIS conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>530C62D8-454E-42FB-93EA-7E4C3F1C6132</gtr:id><gtr:impact>Presented research results at the 3rd congress Termis and discussed the data with other researchers in the field of cartilage tissue engineering.

Many scientists showed interests of our research and collaboration with us.</gtr:impact><gtr:outcomeId>q9GoLGMBXpy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC icase studentship (with Argo)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>1D79F21F-8DDB-4145-961E-A42F23114745</gtr:id><gtr:outcomeId>546369cf90f217.69073626</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1180000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EU FP7, Sybil; Systems Biology for the functional validation of genetic determinants of skeletal diseases.</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>8B2580E7-7D4C-4E9F-9704-38308EA944DF</gtr:id><gtr:outcomeId>D5MDExc2M2j</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>468000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TSB - Expandable clinical grade feeder cells for hESc derivation</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>DFCEE8B7-E31B-4E46-8FCA-2F85F0772CD2</gtr:id><gtr:outcomeId>inYEbHDLpu50</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - EFREEZE</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>78085836-6E3C-4CD7-BA7A-3DC573EB0A8D</gtr:id><gtr:outcomeId>54636acfd39497.99464740</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UKRMP (inter-University strategic grant) hub Safety of Stem cells</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Research Councils UK (RCUK)</gtr:fundingOrg><gtr:fundingRef>MR/K026739</gtr:fundingRef><gtr:id>83D5C976-9A5C-4D13-A983-059B99BA5357</gtr:id><gtr:outcomeId>gE82YRwnW7x</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>570000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>C3531554-A818-4662-8DCE-12AF84D48E96</gtr:id><gtr:outcomeId>56dde3c93b1d21.89024504</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Grant funding</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>Newlife</gtr:fundingOrg><gtr:id>576A2A54-4115-4111-80FB-8DC03EE06394</gtr:id><gtr:outcomeId>58bb111c60e0b7.20993192</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1290000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>7A763644-8371-4237-80C6-F0167FFF3FE8</gtr:id><gtr:outcomeId>56dde5b09b9aa1.93333904</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Toxicology programme</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D95ECFB8-FFCD-466D-97E7-67AF265B6497</gtr:id><gtr:outcomeId>546369685a62f5.37018931</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>270000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Clinical fellowship</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>EF097198-1D7B-413E-BAAA-8476A2E3226E</gtr:id><gtr:outcomeId>56dde48f1c97f3.35792053</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>793000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Chondrocytes from clinical grade embryonic stem cells</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L004992/1</gtr:fundingRef><gtr:id>2BE11213-2E9A-4F23-B56F-96722120727E</gtr:id><gtr:outcomeId>54636c78631606.93067965</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>793000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC (with Hardingham and Brison) Chondrocytes from clinical grade embryonic stem cells</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L004992/1</gtr:fundingRef><gtr:id>E130D6D3-B5A8-4930-941F-C9811C6B5F0D</gtr:id><gtr:outcomeId>EfY1Xk2nmn7</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>385264</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EpiHealth: Linking perturbed maternal environment during periconceptional development, due to diabetes, obesity or assisted reproductive technologies, and altered health during ageing. Grant agreement number: 278418</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>D61636CA-9B61-4E2F-9AF5-7E1FF943F6E4</gtr:id><gtr:outcomeId>DWNsHJnt7cE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285607</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EpiHealthNet</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>C217C082-3DF1-4BA8-B1C7-B831E9F69B1C</gtr:id><gtr:outcomeId>BUWjKm7HvNm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - HaBSelect</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>20FEE22D-668F-43FB-96B2-13D15B6D1E15</gtr:id><gtr:outcomeId>54636a72020ab8.60854298</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK national ART cohort - Population and Systems Medicine Board</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L020335/1</gtr:fundingRef><gtr:id>CE39FD84-A8E9-4F90-BC17-78E4DEF17230</gtr:id><gtr:outcomeId>546367d6a79c04.59498648</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49294</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Technology Strategy Board - Regenerative Medicine Tools &amp;amp; Technologies Feasibility Studies</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>7E6B5B2A-3980-47DA-8988-C8446166EE9D</gtr:id><gtr:outcomeId>C1hbadVMYkr0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>TSB - GMP grade human dermal fibroblasts as feeders for derivation of clinically useable human ES cells</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>BCFB4FAD-38BD-4CA2-8D5C-835A434AF5B8</gtr:id><gtr:outcomeId>kYt6GPHZwn30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>133000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellbeing of Women</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Royal College of Obstetricians and Gynaecologists (RCOG)</gtr:fundingOrg><gtr:id>A2C249B5-FCE2-4F96-AA4B-8A089385890E</gtr:id><gtr:outcomeId>nyb89HDDyXR</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK-China Fellowships for Excellence /Department for Business, Innovation and Skills (BIS)</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Department for Business, Energy &amp; Industrial Strategy</gtr:fundingOrg><gtr:id>B37D797D-3E54-4406-A6A9-D7DE35856998</gtr:id><gtr:outcomeId>DFFWAJ7PxqN0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>195453</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Arthritis Research UK Project Grant</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Arthritis Research UK</gtr:fundingOrg><gtr:id>AA3BC063-2016-4047-8F67-CC501E3C1D3D</gtr:id><gtr:outcomeId>BdyicEK5AUY0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This described development of a three stage culture process for obtaining cells to repair articular cartilage from hESc</gtr:description><gtr:grantRef>G0801057</gtr:grantRef><gtr:id>9F43637C-6290-4906-9107-9D00F2CC7C1E</gtr:id><gtr:impact>Pending</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>k2NN2s7bcxm</gtr:outcomeId><gtr:patentId>GB1012495.6</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Generation of chondrogenic cells from human Embryonic Stem Cells</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stem Cells for Safer Medicine Panel Member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D28B416E-6A3A-498D-A6FD-B09C1E671AAB</gtr:id><gtr:outcomeId>myxbn9Peruf</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HFEA Information for Quality programme</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>00ACE244-706F-4D42-9D5A-423763DFE1A8</gtr:id><gtr:impact>acting as advisor to Human Fertilisation and Embryology Authority Information for quality programme which aims to improve regulatory oversight of the field including stem cell derivation, and improve information to patients and for delivery of clinical IVF services.</gtr:impact><gtr:outcomeId>5463b792049bb2.03091056</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Setting standards for procurement of embryonic stem cells at clinical grade</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E658A338-1534-4579-ABAF-2BCDA6085D39</gtr:id><gtr:outcomeId>YykAiDHyyri</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Clinical human Embryonic Stem Cell Forum</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A1646632-FD36-4240-A8F3-976021CE6524</gtr:id><gtr:impact>Standardisation of requirements for clinical grade embryonic stem cell lines. Prof Brison is vice-chair of this group</gtr:impact><gtr:outcomeId>JDzv2iuj9pu</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influencing policy towards patenting of discoveries using hESC lines</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>D693C8CE-F1B1-46EE-A62E-3AF6BF25EB94</gtr:id><gtr:outcomeId>rSU1QnSGJkR</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cochrane guideline on embryo culture temperature</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>73C93080-CE52-4AE8-B85B-0BA46D4AAB43</gtr:id><gtr:outcomeId>56def31820d975.88069617</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ESHRE working group on the impact of embryo culture medium on long term health</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>08970A43-E41C-41CF-A924-D618201A439C</gtr:id><gtr:outcomeId>56def2c72e6bf9.57948647</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of TERMIS Scientific Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>648E569D-1A45-48B2-9C0D-ABDD141F40B7</gtr:id><gtr:outcomeId>magqDeYGPsY</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of HFEA's Scientific and Clinical Advances committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>51378DF9-A96C-4540-A367-D51FE81EB1E4</gtr:id><gtr:impact>Advising the HFEA on changes in regulation on embryology and embryonic stem cell biology</gtr:impact><gtr:outcomeId>enWpVaz3Rgt</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Habselect; NIHR-funded prospective clinical trial of sperm selection in ART</gtr:description><gtr:id>B33D20A0-B698-4458-A579-7DDE6A10F8D5</gtr:id><gtr:impact>Habselect; NIHR-funded prospective clinical trial of sperm selection in ART</gtr:impact><gtr:outcomeId>56defa01e94933.62961522</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Habselect;  NIHR-funded prospective clinical trial of sperm selection in ART</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A novel method of derivation of human embryonic stem cell lines.</gtr:description><gtr:id>BB476CDC-EC91-49BD-83D0-B01917EBC5B1</gtr:id><gtr:impact>Increased success rate at deriving stem cell lines.</gtr:impact><gtr:outcomeId>sEvaKoa5Lmv</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>A novel method of derivation of human embryonic stem cell lines</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>protocol for deriving chondrocyte progenitor cells for cartilage repair. Next stage of work funded by MRC to translate protocol to clinical grade with pre-clinical animal testing</gtr:description><gtr:id>4D1AB5C8-C19C-42B4-B647-931B43FAD78D</gtr:id><gtr:impact>impacts potential not yet realised</gtr:impact><gtr:outcomeId>M4QCkbx73S7</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Protocol for genererating chondrocyte pro-genitor cells from embryonic stem cells</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>HTA - 13/115/82: E-FREEZE: a randomised controlled trial evaluating the clinical and cost-effectiveness of a policy of freezing all embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in-vitro fertilization</gtr:description><gtr:id>16555574-8506-4144-A413-D28F84BD2734</gtr:id><gtr:impact>HTA - 13/115/82: E-FREEZE: a randomised controlled trial evaluating the clinical and cost-effectiveness of a policy of freezing all embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in-vitro fertilization</gtr:impact><gtr:outcomeId>56defac1109231.63771355</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>HTA - 13/115/82: E-FREEZE: a randomised controlled trial evaluating the clinical and cost-effectiveness of a policy of freezing all embryos followed by thawed frozen embryo transfer, compared with a policy of fresh embryo transfer in women undergoing in-vitro fertilization</gtr:title><gtr:type>Therapeutic Intervention - Medical Devices</gtr:type><gtr:ukcrnIsctnId>13/115/82</gtr:ukcrnIsctnId><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>amplified cDNAs from individual human embryos suitable for gene expression analysis</gtr:description><gtr:id>C02794D0-9013-4ADD-A885-F84D53AECBB9</gtr:id><gtr:impact>Sneddon et al 2012 paper</gtr:impact><gtr:outcomeId>Gria1VoAXEB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>embryo cDNAs</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human embryonic stem cell lines which have been derived and stored at clinical grade standards suitable for use in clinical therapies.</gtr:description><gtr:id>9F96D30F-7AA9-46A4-951A-C8721274DF03</gtr:id><gtr:impact>Not known yet</gtr:impact><gtr:outcomeId>XzreUKXXWwG</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Clinical grade human embryonic stem cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>gene expression data from single human embryos available for bioinformatic analysis</gtr:description><gtr:id>EEFB3776-F5A3-4C95-BEB5-2BFA5936FC8D</gtr:id><gtr:impact>publications in preparation</gtr:impact><gtr:outcomeId>PAhWY17YZKV</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>embryo microarray data</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Human embryonic stem cell lines. Research grade and clinical grade.</gtr:description><gtr:id>A168187A-DB5C-4857-A6BF-5D7153AE912A</gtr:id><gtr:impact>ISCI2 project on genetic characterisation of lines (see nature Biotechnology publication).</gtr:impact><gtr:outcomeId>RQEB1oCZtgr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>More human Embyonic Stem Cell lines, including xeno-free lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Manchester Clinical grade hESCs now registered as EUCTD compliant and launched by Stem Cell bank</gtr:description><gtr:id>471FD8B3-5276-4E5E-8E3C-9DB714DA3F16</gtr:id><gtr:impact>Provision at research grade lines in in 2015. Lead to several papers from Hay and Kunath groups. Now available as clinical grade though UKSCB</gtr:impact><gtr:outcomeId>58bb2d95c5f793.56255733</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Six Clinical grade Manchester hESC lined completed due diligence and made avialble by UKSCB</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>human Embryonic Stem Cell lines</gtr:description><gtr:id>7CF7E299-9E7F-4CDA-B0B2-0E6B66D8314C</gtr:id><gtr:impact>Results not yet known.</gtr:impact><gtr:outcomeId>abMN2WgqFZr</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>human Embryonic Stem Cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Intercytex PLC</gtr:companyName><gtr:description>ICX</gtr:description><gtr:id>F97EB5CB-BDC9-4B75-8979-62BAD1C49899</gtr:id><gtr:impact>Joint running of GMP cleanrooms with ICX has allowed them to develop their products. Joint research on human feeder cells will potentially allow them to further develop markets for their products.</gtr:impact><gtr:outcomeId>aQtiqwE1K61</gtr:outcomeId><gtr:url>http://www.intercytex.com/</gtr:url></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>B4AD2CCB-2FDC-4577-B75D-F24D4E044568</gtr:id><gtr:title>Directed differentiation of human embryonic stem cells toward chondrocytes.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/467776764ace099b543fb001950b0983"><gtr:id>467776764ace099b543fb001950b0983</gtr:id><gtr:otherNames>Oldershaw RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>56d9cc53e8d673.25996197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0024E67-1AC1-4A6F-BE46-651EDB825476</gtr:id><gtr:title>Clinically failed eggs as a source of normal human embryo stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>pm_15264_14_19393594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2D03216-FAAB-42E4-B4A1-7F5F68A66380</gtr:id><gtr:title>High&amp;nbsp;quality clinical&amp;nbsp;grade human embryonic stem cell lines derived from fresh discarded embryos.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a90b8668bf1ae56a3720e400c75a3497"><gtr:id>a90b8668bf1ae56a3720e400c75a3497</gtr:id><gtr:otherNames>Ye J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>5a9e9e1b41ca84.18673617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42CEE734-4349-47BF-A85C-F02BDFDD91DB</gtr:id><gtr:title>ACE consensus meeting report: culture systems.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/209bbf8a071fc6234a1542a2569ff08e"><gtr:id>209bbf8a071fc6234a1542a2569ff08e</gtr:id><gtr:otherNames>Bolton VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cc3f0169.93698456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FBF9A8A-2DF7-414E-8950-AEDA8B0B42FE</gtr:id><gtr:title>How should we assess the safety of IVF technologies?</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>pm_15264_24_24145118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6F8C8D4-A221-43BE-87E3-05346D3DBE6C</gtr:id><gtr:title>Current evidence for ART practice: the Cochrane of Cochranes on optimising outcomes.</gtr:title><gtr:parentPublicationTitle>Evidence-based medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6745dc9d496018514a97679b9b676727"><gtr:id>6745dc9d496018514a97679b9b676727</gtr:id><gtr:otherNames>Harper JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1356-5524</gtr:issn><gtr:outcomeId>546362cbe187f4.95407788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED582E11-34DF-4B56-B97B-8A3733CB6533</gtr:id><gtr:title>Reducing the incidence of twins from IVF treatments: predictive modelling from a retrospective cohort.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc539bbba2.14972101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B45C8FA-3B6A-4E6F-B48E-A21625FA574E</gtr:id><gtr:title>Secondary cell walls: biosynthesis and manipulation.</gtr:title><gtr:parentPublicationTitle>Journal of experimental botany</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b485f54ccbe8b234fd358601646f7b6d"><gtr:id>b485f54ccbe8b234fd358601646f7b6d</gtr:id><gtr:otherNames>Kumar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-0957</gtr:issn><gtr:outcomeId>585d732fda79e9.87734843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1AB1907-F4AA-4731-A035-087B6E83F316</gtr:id><gtr:title>Generating cartilage repair from pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>pm_15264_24_23957872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F21A0729-A734-4F6B-87A1-8367D8DA7B83</gtr:id><gtr:title>Metabolic heterogeneity during preimplantation development: the missing link?</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn><gtr:outcomeId>546362cc152139.43556606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>373E951A-D5E3-4CD9-A801-F35ACAFB3236</gtr:id><gtr:title>The use of single embryo transfer to reduce the incidence of twins: Implications and questions for practice from the 'towardSET?' project.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc535a7d53.74213134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA36A3CE-A197-4B03-B3D8-223A403916F7</gtr:id><gtr:title>Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bc335b9058c25ae59c2c91c49d66f3"><gtr:id>a8bc335b9058c25ae59c2c91c49d66f3</gtr:id><gtr:otherNames>Garcia-Alegria E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bb1d9562b348.31302989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C0B4B98-4941-45E3-8162-49A9A3AFD700</gtr:id><gtr:title>Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a58d69ad4f17dd544ce82aba3158212b"><gtr:id>a58d69ad4f17dd544ce82aba3158212b</gtr:id><gtr:otherNames>Cameron K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>585d679d1d57d0.24171846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6C8F67F-4B4F-490D-8B41-91E717DEE048</gtr:id><gtr:title>Modelling the impact of single embryo transfer in a national health service IVF programme.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc556d81f1.59601993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEBA0BD3-ED50-46CB-9E3C-52B96DB9FDDC</gtr:id><gtr:title>Naturally immortalised mouse embryonic fibroblast lines support human embryonic stem cell growth.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad8f07a1e0b5b86dc4f9bbfb7c459893"><gtr:id>ad8f07a1e0b5b86dc4f9bbfb7c459893</gtr:id><gtr:otherNames>Camarasa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn><gtr:outcomeId>pm_15264_14_19594387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1D6A4C2-3D88-44F2-9C62-77B2B001E7D2</gtr:id><gtr:title>No common denominator: a review of outcome measures in IVF RCTs.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f9605c5e32e31e25cde9b73007beb93"><gtr:id>9f9605c5e32e31e25cde9b73007beb93</gtr:id><gtr:otherNames>Wilkinson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c273e41bc1.06220520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C81E896-7065-4C0C-8AB5-36031785682D</gtr:id><gtr:title>Derivation of the human embryonic stem cell line RCM1.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>58c2c274730242.97959541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2BE47D5-0F36-4B66-AFF6-FBFE1132D701</gtr:id><gtr:title>MiR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b22fd142b550e7e1b873d06726a9af"><gtr:id>61b22fd142b550e7e1b873d06726a9af</gtr:id><gtr:otherNames>Kang YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56d9cd5cdd5452.26011916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DA07692-321A-467E-88E3-ECF4945A5B1F</gtr:id><gtr:title>Corrigendum: Graphene Oxide promotes embryonic stem cell differentiation to haematopoietic lineage.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8bc335b9058c25ae59c2c91c49d66f3"><gtr:id>a8bc335b9058c25ae59c2c91c49d66f3</gtr:id><gtr:otherNames>Garcia-Alegria E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58bb1d959d03c4.65748597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C90FD85-5AA3-4FC8-8A54-ADCEF3C35DD1</gtr:id><gtr:title>Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88faafb158d268b797c8d4d26509a188"><gtr:id>88faafb158d268b797c8d4d26509a188</gtr:id><gtr:otherNames>Villarin BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>5675e7477f915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C62956D3-9E57-4873-A5B6-4CB07BEB917E</gtr:id><gtr:title>Optimized protocol for derivation of human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeddc0f73525a60b36da7bf0b7dbad5"><gtr:id>aeeddc0f73525a60b36da7bf0b7dbad5</gtr:id><gtr:otherNames>Camarasa MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>pm_15264_24_22614996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C48F7EB7-0523-488B-859A-D73E4B16EA31</gtr:id><gtr:title>When and how should new technology be introduced into the IVF laboratory?</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17036ea8e84d55655caae17c174bef6a"><gtr:id>17036ea8e84d55655caae17c174bef6a</gtr:id><gtr:otherNames>Harper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc55b64e91.50826940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AEC80E-989F-417B-A7B2-9E3930230858</gtr:id><gtr:title>The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93977d2ba9fe935c99b3418690c14eaf"><gtr:id>93977d2ba9fe935c99b3418690c14eaf</gtr:id><gtr:otherNames>Canham MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d9cc52d88874.18293894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D06E31A7-B1C3-468B-8804-79F5D2933CF3</gtr:id><gtr:title>Embryo and uterine influences on IVF outcomes: an analysis of a UK multi-centre cohort.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc5418f3c6.08952205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDA81CD5-D1D6-491A-A6FE-3A517DFDD960</gtr:id><gtr:title>Stem Cell Reports</gtr:title><gtr:parentPublicationTitle>Stem Cell Reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd15cf06b449d2cf5171f81c3594a1f7"><gtr:id>dd15cf06b449d2cf5171f81c3594a1f7</gtr:id><gtr:otherNames>Canham M</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>565dd2ce447e56.20600945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>397E5D70-AFC6-40A5-A912-962EF4ED44E1</gtr:id><gtr:title>Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a14ab8d4d51dac3af2b2d3d0bb6f062"><gtr:id>2a14ab8d4d51dac3af2b2d3d0bb6f062</gtr:id><gtr:otherNames>Harbottle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc543d9a09.74142785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DE55301-BA70-4198-A37B-C409FE48431A</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>jzFxKPfjCpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0132B8B5-A1EF-4C31-8DB5-78CD6FA1C198</gtr:id><gtr:title>Human feeder cell line for derivation and culture of hESc/hiPSc.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d233ec7c88eeed0e8516efa547bc6e9"><gtr:id>6d233ec7c88eeed0e8516efa547bc6e9</gtr:id><gtr:otherNames>McKay TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56d9cc533589f7.53039517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>179FE694-0902-4064-B019-18CE3654042E</gtr:id><gtr:title>Time to take human embryo culture seriously.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ea5b5fbc9b3dced0d706343485c6bd9"><gtr:id>1ea5b5fbc9b3dced0d706343485c6bd9</gtr:id><gtr:otherNames>Sunde A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c2741c1f75.64881741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DA332E0-9BDB-48F5-A192-A8667C0143F4</gtr:id><gtr:title>Prognostic factors influencing fresh and frozen IVF outcomes: an analysis of the UK national database.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c51df207093de5199ab22532ef58862"><gtr:id>0c51df207093de5199ab22532ef58862</gtr:id><gtr:otherNames>Hirst WM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>56d9cc537bc6d6.23328587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B675FF6-CDD9-490D-8A61-7D24C94008C5</gtr:id><gtr:title>Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeddc0f73525a60b36da7bf0b7dbad5"><gtr:id>aeeddc0f73525a60b36da7bf0b7dbad5</gtr:id><gtr:otherNames>Camarasa MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>56d9cc548d4301.74035907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3842142E-2801-4792-A2BC-BEF4EAD92D86</gtr:id><gtr:title>Alkylation of sperm DNA is associated with male factor infertility and a reduction in the proportion of oocytes fertilised during assisted reproduction.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c66517cfba3d0931b2c12ef8a4b9a38"><gtr:id>0c66517cfba3d0931b2c12ef8a4b9a38</gtr:id><gtr:otherNames>Stocks SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>56d9cc5467e832.15969435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8F3F87B-2552-4CAE-9208-2D28AFC83808</gtr:id><gtr:title>Testing for hypersensitivity to seminal fluid-free spermatozoa.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/748e4b4c02ccd873019dbeba2f0eb633"><gtr:id>748e4b4c02ccd873019dbeba2f0eb633</gtr:id><gtr:otherNames>Carroll M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cbbd47c1.98998652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40B02B02-78DC-4CBB-9E72-B296EA64EBF2</gtr:id><gtr:title>Comparison of gene expression in fresh and frozen-thawed human preimplantation embryos.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pm_15264_24_22996807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02F86EBB-BAE5-4121-9600-0C5E2ED7A5C7</gtr:id><gtr:title>Cartilage repair using human embryonic stem cell-derived chondroprogenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>5463642c2e2f32.44160384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D980BA8C-62C6-4C73-B67E-FDBC9D6DABB6</gtr:id><gtr:title>Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d992313132f7fc5b483dddbe10900065"><gtr:id>d992313132f7fc5b483dddbe10900065</gtr:id><gtr:otherNames>Soteriou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15264_24_23658023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C32B77F-5FA0-4BD0-B049-391947E86613</gtr:id><gtr:title>ACE consensus meeting report: oocyte and embryo cryopreservation Sheffield 17.05.11.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f9e96ff3845365a47234edf4e05a8ff"><gtr:id>1f9e96ff3845365a47234edf4e05a8ff</gtr:id><gtr:otherNames>Brison D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc54b57991.70372026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A6437B9-C769-4674-BAC8-595161CDDF92</gtr:id><gtr:title>Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0061725cba620664df0b93abfff78c48"><gtr:id>0061725cba620664df0b93abfff78c48</gtr:id><gtr:otherNames>Roberts S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>58c2c2754b88e8.50416268</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C49CA5A-54D2-4420-B0B1-09E04F526B67</gtr:id><gtr:title>Sox2 is essential for formation of trophectoderm in the preimplantation embryo.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4ee4d9bcbab079c3db06775036a85b7"><gtr:id>d4ee4d9bcbab079c3db06775036a85b7</gtr:id><gtr:otherNames>Keramari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d9cd5d2b2ec5.48139927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A66B38B4-86D6-4183-835A-33542962E51C</gtr:id><gtr:title>Embryo morphology as a predictor of IVF success: an evaluation of the proposed UK ACE grading scheme for cleavage stage embryos.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db12c120e91a7fdacb8eca718fe5e7fd"><gtr:id>db12c120e91a7fdacb8eca718fe5e7fd</gtr:id><gtr:otherNames>Stylianou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc5310b6f8.23110781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB1EB795-01C9-47BA-8D7E-CDA1F7034772</gtr:id><gtr:title>Biological optimization, the Goldilocks principle, and how much is lagom in the preimplantation embryo.</gtr:title><gtr:parentPublicationTitle>Molecular reproduction and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc86168aa0009a12492b860b6e9a88c1"><gtr:id>bc86168aa0009a12492b860b6e9a88c1</gtr:id><gtr:otherNames>Leese HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1040-452X</gtr:issn><gtr:outcomeId>58c2c27443da10.13072325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B72F9A5-FDF6-4DE2-BD65-995A5FF9E6C8</gtr:id><gtr:title>The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ae23803e6e96e9fac7081387c099d5"><gtr:id>f0ae23803e6e96e9fac7081387c099d5</gtr:id><gtr:otherNames>Murdoch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>56d9cc54e47b64.23834938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BC0CFDC-69E8-4BB9-8739-EA58E439EA6B</gtr:id><gtr:title>Global gene expression profiling of individual human oocytes and embryos demonstrates heterogeneity in early development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15264_24_23717564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9756C7F-CC27-4F19-A87A-780B0B2C4BE6</gtr:id><gtr:title>Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9ba1569cd98c74f7d57fc9f3abdeef5"><gtr:id>f9ba1569cd98c74f7d57fc9f3abdeef5</gtr:id><gtr:otherNames>Baxter MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56d9cd5d64b735.19103166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7522A543-6DA4-4505-92BB-69D1177270F2</gtr:id><gtr:title>Gene expression analysis of a new source of human oocytes and embryos for research and human embryonic stem cell derivation.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4931d24d2dd4026a98cbdb093c07d493"><gtr:id>4931d24d2dd4026a98cbdb093c07d493</gtr:id><gtr:otherNames>Sneddon SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>56d9cc53c528d5.91402441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBC593BA-DBE3-4A2A-A242-E5E8F85968F0</gtr:id><gtr:title>High&amp;nbsp;quality clinical&amp;nbsp;grade human embryonic stem cell lines derived from fresh discarded embryos.</gtr:title><gtr:parentPublicationTitle>Stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a90b8668bf1ae56a3720e400c75a3497"><gtr:id>a90b8668bf1ae56a3720e400c75a3497</gtr:id><gtr:otherNames>Ye J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1757-6512</gtr:issn><gtr:outcomeId>5a361eb439fb07.37268600</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801057</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>